Insights from 2024 ASCO® GI Annual Meeting

 

Insights from 2024 ASCO® GI Annual Meeting
G

ASCO® GI 2024 Insights: "PROOF 301 Trial - Oral FGFR Inhibitor Infigratinib vs. Gemcitabine + Cisplatin in Patients With Advanced Cholangiocarcinoma With an FGFR2 Gene Fusion/Rearrangement"

By Insights from 2024 ASCO® GI Annual Meeting FEATURING Ghassan Abou-Alfa
By Insights from 2024 ASCO® GI Annual Meeting FEATURING Ghassan Abou-Alfa
172 views
January 31, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

20:14
Exelixis

Hypothetical Patient Case: RAI-R Metastatic Differentiated Thyroid C…

Feat. R. Alter, R. Shameem

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss
Videos
04:14

ASCO® 2024 Insights: "FRESCO-2 Trial - Q-TWiST Analysis of Fruquinti…

Insights from 2024 ASCO® GI Annual Meeting

S. Stintzing

39 views
11:03

Final Analyses From INTRIGUE: OS & Long-Term Safety With Ripretinib …

Insights from 2024 ASCO® GI Annual Meeting

J. Zalcberg

178 views
10:48

INSIGHT: A Phase 3 Study of Ripretinib vs. Sunitinib in Pts With Adv…

Insights from 2024 ASCO® GI Annual Meeting

J. Zalcberg

186 views
09:19

ASCO® GI 2024 Insights: "LIBRETTO-001 Study - Durable Efficacy of Se…

Insights from 2024 ASCO® GI Annual Meeting

V. Subbiah

45 views
10:36

ASCO® GI 2024 Insights: "Advanced Pancreatic Ductal Adenocarcinoma -…

Insights from 2024 ASCO® GI Annual Meeting

M. Kundranda

80 views
15:18

ASCO® GI 2024 Insights: "Case Presentation on Upper GI Malignancies …

Insights from 2024 ASCO® GI Annual Meeting

N. Uboha

113 views
12:22

ASCO® GI 2024 Insights: "Neoadjuvant Immunotherapy in Localized MSI-…

Insights from 2024 ASCO® GI Annual Meeting

S. Chakrabarti

60 views
07:41

ASCO® GI 2024 Insights: "Bi-Weekly FTD/TPI + Bevacizumab vs. FTD/TPI…

Insights from 2024 ASCO® GI Annual Meeting

H. Satake

55 views
15:54

ASCO® GI 2024 Insights: "Evolving Treatment Paradigms in Rectal Canc…

Insights from 2024 ASCO® GI Annual Meeting

K. Jethwa

101 views
05:11

ASCO® GI 2024 Insights: "INTERCEPT Program of ctDNA Testing for MRD …

Insights from 2024 ASCO® GI Annual Meeting

G. Maddalena

55 views
19:41

ASCO® GI 2024 Insights: "Emerging Data and Ongoing Trials With Zanza…

Insights from 2024 ASCO® GI Annual Meeting

A. Saeed

81 views
09:32

ASCO® GI 2024 Panel Discussion: "ctDNA in Colon Cancer - GALAXY, BES…

Insights from 2024 ASCO® GI Annual Meeting

Y. Janjigian, S. Cytryn, S. Klempner

599 views
07:16

ASCO® GI 2024 Panel Discussion: "CheckMate-8HW Clinical Implications…

Insights from 2024 ASCO® GI Annual Meeting

Y. Janjigian, S. Cytryn, S. Klempner

326 views
09:42

ASCO® GI 2024 Panel Discussion: "MATTERHORN & KEYNOTE-585 Clinical I…

Insights from 2024 ASCO® GI Annual Meeting

Y. Janjigian, S. Cytryn, S. Klempner

405 views
06:53

ASCO® GI 2024 Panel Discussion: "SKYSCRAPER-08 Clinical Implications…

Insights from 2024 ASCO® GI Annual Meeting

Y. Janjigian, S. Cytryn, S. Klempner

233 views
09:11

ASCO® GI 2024 Insights: "Evaluating Novel Therapies and ctDNA as a M…

Insights from 2024 ASCO® GI Annual Meeting

R. Mukherji

148 views
12:13

ASCO® GI 2024 Insights: "GALAXY Study in CIRCULATE-Japan - Predictin…

Insights from 2024 ASCO® GI Annual Meeting

K. Kaneva

167 views
09:56

ASCO® GI 2024 Insights: "Clinical Validation of Northstar Response, …

Insights from 2024 ASCO® GI Annual Meeting

I. Sahin

65 views
11:34

ASCO® GI 2024 Insights: "NRG-GI005 (COBRA) Study - ctDNA as a Predic…

Insights from 2024 ASCO® GI Annual Meeting

V. Morris

300 views
11:50

ASCO® GI 2024 Summary: "CRC Key Studies Including BESPOKE & KEYNOTE-…

Insights from 2024 ASCO® GI Annual Meeting

R. Kim, T. Biachi

473 views
13:58

ASCO® GI 2024 Summary: "HCC Key Studies Including EMERALD-1 & IMbrav…

Insights from 2024 ASCO® GI Annual Meeting

R. Kim, T. Biachi

434 views
04:31

ASCO® GI 2024 Insights: "NIVOFGFR2 Study - Nivo and CapeOX in Patien…

Insights from 2024 ASCO® GI Annual Meeting

I. Tsimafeyeu

103 views
04:39

ASCO® GI 2024 Insights: "PROOF 301 Trial - Oral FGFR Inhibitor Infig…

Insights from 2024 ASCO® GI Annual Meeting

G. Abou-Alfa

172 views
05:50

ASCO® GI 2024 Insights: "KEYSTEP-004 Study - Coformulated Quavonlima…

Insights from 2024 ASCO® GI Annual Meeting

L. Rimassa

156 views
07:03

ASCO® GI 2024 Insights: "FRESCO-2 trial - Quality-Adjusted Time With…

Insights from 2024 ASCO® GI Annual Meeting

S. Stintzing

150 views
07:35

ASCO® GI 2024 Summary: "Gastro-Esophageal Key Studies Including KEYN…

Insights from 2024 ASCO® GI Annual Meeting

R. Kim, R. Mehta

488 views
17:23

ASCO® GI 2024 Summary: "Esophageal Squamous Cell Carcinoma Key Studi…

Insights from 2024 ASCO® GI Annual Meeting

R. Kim, R. Mehta

439 views